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Abstract
Introduction: While protective plasma cells (PCs) are an important part of the individual’s immune defense,
autoreactive plasma cells such as dsDNA-specific plasma cells contribute to the pathogenesis of autoimmune
diseases like systemic lupus erythematosus (SLE). However, the research on dsDNA-specific plasma cells was
restricted to the ELISpot technique, with its limitations, as no other attempt for identification of dsDNA-reactive
plasma cells had been successful.
Methods: With improved fluorochrome labeling of dsDNA, removal of DNA aggregates, and enhanced blocking of
unspecific binding, we were able to specifically detect dsDNA-reactive plasma cells by immunofluorescence microscopy.
Results: Via this novel technique we were able to distinguish short-lived (SLPCs) and long-lived (LLPCs) autoreactive
plasma cells, discriminate dsDNA-specific plasma cells according to their immunoglobulin class (IgG, IgM, and IgA) and
investigate autoreactive (dsDNA) and vaccine-induced ovalbumin (Ova) plasma cells in parallel.
Conclusions: The detection of autoreactive dsDNA-specific plasma cells via immunofluorescence microscopy allows
specific studies on pathogenic and protective plasma cell subsets and their niches, detailed evaluation of therapeutic
treatments and therefore offers new possibilities for basic and clinical research.
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Introduction
Pathogenic self-reactive plasma cells (PCs) have been in
the focus of autoimmunity research for many years
since they contribute to the onset and maintenance of
the disease [1–5]. In humans and mice alike antinuclear
antibodies (ANAs) are a main feature and hallmark of
autoimmunity [6]. In systemic lupus erythematosus
(SLE) especially, double-stranded deoxyribonucleic acid
(dsDNA)-specific autoantibodies are associated with
the pathogenesis and correlate with disease activity [7].
Antibodies against dsDNA are produced by short-lived
(SLPCs) and long-lived plasma cells (LLPCs). While the
first are mainly associated with flares the latter are
refractory against most immunosuppressive treatments
and contribute to chronicity and relapses of the disease
[1]. However, LLPCs are not long-lived per se but need
permanent anti-apoptotic stimuli, which are supplied
by the microenvironment. This so-called survival niche
[2] consists of stromal (SNC) and hematopoietic niche
components (HNCs) [8, 9]. Most data about LLPCs are
acquired by studies on total PCs or from responses
against protein model vaccines for protective PCs such
as ovalbumin (Ova). In contrast, the knowledge about
pathogenic dsDNA-specific PCs is rare as no identifi-
cation of dsDNA-specific PCs has been possible in
histology. However, detailed and comparative studies
appear essential as many aspects, such as the character-
istics of the antigen or the B cell stimulation/activation
route, modify the PC fate and the turnover within the
memory PC compartment [10–13]. Moreover, subsets
of memory PCs may reside in alternative niches [14, 15],
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which might be differently modified by therapeutic treat-
ments [16].
All these factors influence the protective and patho-
genic humoral memory, disease progression and thera-
peutic success. Thus, we wanted to establish a method
that allows the identification of autoreactive (dsDNA-
specific) PCs and comparative studies with PCs of differ-
ent antigen specificities (e.g., pathogenic (dsDNA) vs.
protective (Ova) PCs) within the tissue. Moreover, the
method should enable a distinction of dsDNA LLPCs
and SLPCs, investigation of dsDNA PCs of different im-
munoglobulin (Ig) classes and the evaluation of thera-
peutic treatments.
Methods
Mouse strains and treatments
Female mice from autoimmune (NZB/W F1 and BcN/
LmoJ) and non-autoimmune (C57BL/6) strains were
bred at the animal facility of the Deutsches Rheuma-
Forschungszentrum (DRFZ) and C57BL/6 mice with experi-
mental autoimmune myasthenia gravis (EAMG) were kept
at the animal facility of the Charité - Universitätsmedizin
Berlin under defined pathogenic-free conditions and treat-
ments were approved (approval number G130/08, G113/
10 and G0172/13) by the Landesamt für Gesundheit und
Soziales (LaGeSo) Berlin, Germany. All animal experi-
ments were performed by certified personnel and all ef-
forts were made to minimize suffering. For dsDNA
analysis, mice with positive dsDNA antibody titer (be-
tween 5 and 7 months old) and age-matched controls
were chosen. Experimental autoimmune myasthenia
gravis was induced by three intraperitoneal injections of
torpedo acetylcholine receptor (AChR) in Freund’s
complete adjuvant into 3-month-old C57BL/6 mice at 4-
week intervals. Mice were sacrificed for analysis 17 days
after the last injection at an age of 6 months and after
conformation of active EAMG by positive anti-AChR anti-
body titer and disease score [17]. For distinction of auto-
reactive LLPCs and SLPCs, 6-month-old BcN/LmoJ mice
(another mouse model with genetic predisposition for
SLE, which was backcrossed to the C57BL/6 strain
and thus is also known as the B6.Sle123 strain [18])
with positive dsDNA antibody titer were fed 5-ethynyl-2′-
deoxyuridine (EdU) (0.3 mg/ml) for 2 weeks.
Labeling of dsDNA
Five hundred micrograms of dsDNA (activated dsDNA
from calf thymus (Sigma-Aldrich Chemie GmbH, Munich,
Germany)) in 500 μl phosphate-buffered saline (PBS) was
reduced with 10 μl 0.5 mol/l dithiothreitol for 30 min at
room temperature. Subsequently, the labeling solution
was rebuffered with Amicon Ultra (10 kDa) in borate
buffer (pH9.5) with 10 mg/ml DMSO containing 20 μl
digoxigenine (dig-NHS, Sigma-Aldrich) and incubated
for 1 h at room temperature in the dark. After labeling,
reaction-free dig was removed in a PD10 desalting col-
umn equilibrated with PBS/0.05 % azide and fractions
containing high concentrations of labeled dsDNA were
collected and pooled.
Sample preparation and immunofluorescence staining for
histology
Spleen and bone marrow samples were embedded in
O.C.T. compound medium (Sakura Alphen aan den Rijn,
The Netherlands) in cryomold vessels, snap frozen in liquid
nitrogen for 10 min and stored at −80 °C. Kryosections of
8 μm thickness were prepared and subsequently fixated
with acetone at −20 °C for 10 min, air dried and
stored at −80 °C.
For blocking, sections were rehydrated with RPMI
1640 medium (Gibco, Waltham, MA, USA) containing
10 % fetal calf serum (FCS) and anti-FcyRII/III antibody
(clone 2.4G2, DRFZ). Samples for antigen-blocking con-
trol additionally contained unlabeled dsDNA (7 μl of
1 mg/ml to 70 μl). After 1 h, dsDNA-dig was centrifuged
to remove DNA aggregates and immediately added to
the sample. Sections were incubated overnight at 4 °C.
The following day, samples were washed and incubated
with anti-Ig light chain kappa (IgL)-rPE (clone 187.1,
DRFZ) for plasma cell identification [19]. The secondary
staining solution containing anti-dig-Cy5 (prepared and
labeled at DRFZ) was applied for 30 min. Stained sam-
ples were mounted with fluoromount (Dako, Glostrup,
Denmark) and analyzed by confocal laser scanning mi-
croscopy (Zeiss LSM 710, Zeiss, Oberkochen, Germany).
For parallel staining of pathogenic and protective PCs,
samples were incubated with Ova-FITC (Sigma-Aldrich,
labeled at DRFZ) together with secondary staining
solution.
For identification of Ig-class of dsDNA PCs, sections
were incubated with anti-IgA-bio (goat, Southern-
Biotech, Birmingham, AL, USA), anti-IgG-FITC (rabbit,
SouthernBiotech) and anti-IgM-Pacific blue (clone
M41, DRFZ) instead of anti-IgL and subsequently incu-
bated with streptavidin-rPE (BD Biosciences, Franklin
Lakes, NJ, USA).
For distinction of proliferating SLPCs and non-
proliferating LLPCs, incorporated EdU was detected with
the click-it® EdU kit (Life Technologies, Carlsbad, CA,
USA) according to the manufacturer’s instruction.
ELISpot analysis
Enzymatic ELISpot
Ninety-six-well microtiter plates (Merck Millipore, Billerica,
MA, USA) were precoated with methyl-bovine serum albu-
min (BSA) (Sigma-Aldrich) and subsequently coated with
calf thymus DNA (Sigma-Aldrich) as previously described
[20]. Single-cell suspensions were prepared in RPMI 1640
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medium supplemented with 10 % FCS (Invitrogen,
Waltham, MA, USA), penicillin, streptomycin, and
glutamine (complete medium). The cells were then pi-
petted onto the plates and incubated at 37 °C for 3 h in a
5 % CO2-containing incubator. Afterward, cells were
washed away and plates were incubated with biotin-
labeled goat anti-mouse IgM or IgG (SouthernBiotech)
followed by ExtrAvidin-Alkaline Phosphatase (Sigma-
Aldrich). The spots were developed with NBT/BCIP
(Thermo Fisher Scientific, Waltham, MA, USA) and enu-
merated by an automatic ELISpot Reader (AID Autoim-
mun Diagnostika, Strassberg, Germany) using the ELISpot
Reader software (AID Autoimmun Diagnostika).
Fluorescence ELISpot
Ninety-six-well microtiter plates (Merck Millipore) were
coated with goat anti-mouse IgG and IgM (SouthernBio-
tech) respectively or together. For fluorescence acquisi-
tion of dsDNA-specific PCs the probes were incubated
with dsDNA-dig followed by anti-dig-A594 and for total
PCs with anti-IgG and IgM-bio (SouthernBiotech)
followed by streptavidin-FITC (BD Biosciences). ELISpot
analysis were performed blinded and independently to
histologic analysis.
ELISA
Blood was drawn from the left heart ventricle directly
after cervical dislocation of the mouse. Serum was pre-
pared and analyzed as previously described [21]. Briefly,
96-well microtiter plates were precoated with methyl-
BSA (Sigma-Aldrich; 1 mg/mL) at 37 °C for 3 h and sub-
sequently coated with calf thymus DNA (Sigma-Aldrich;
1 mg/mL) at 4 °C overnight. After blocking with PBS/
3 % BSA, serum was added and incubated overnight at
4 °C. The next day, the ELISA was developed by addition
of biotin-labeled goat anti-mouse IgM or IgG (Southern-
Biotech), ExtrAvidin-peroxidase (Sigma-Aldrich) and TMB
substrate (Thermo Fisher Scientific).
Data analysis and statics
Histology data were analyzed with Zen2012 (Zeiss),
ELISpot data with ELISpot6 (AID Autoimmun Diag-
nostika), and graphs were prepared with Prism 5
(Graphpad Software Inc., San Diego, CA, USA). Re-
sults are expressed as means ± standard deviation (SD)
and groups were compared by unpaired Student’s t
test. Correlation between matched data points from
histologic and ELISpot analysis were calculated via
Pearson test. P values <0.05 were considered signifi-
cant differences or correlation respectively and are in-
dicated by one star (*), values <0.01 with two stars
(**) and values <0.001 with three stars (***).
Results and discussion
Immunofluorescence staining of dsDNA-reactive plasma
cells for histologic analysis
Detecting dsDNA-specific PCs via immunofluorescence
microscopy has not been successful so far due to de-
manding technical challenges of staining with labeled
dsDNA that lead to no or unspecific staining. We could
finally achieve this task by establishing a protocol which
combined several blocking and staining conditions (see
Methods). dsDNA-reactive PCs were identified by IgL
staining and binding of fluorochrome-labeled dsDNA,
while PCs reactive against other antigens were singularly
positive for IgL (Fig. 1a and Additional file 1: Figure S1).
A strong signal from PCs producing dsDNA-binding
antibodies was acquired in the SLE mouse model strain
(NZB/W) while in the non-autoimmune mouse strain
(C57BL/6) or mice with EAMG—a disease that is not as-
sociated with anti-dsDNA antibodies—no to few positive
signals were found (Additional file 1: Figure S1). Blocking
with unlabeled dsDNA suppressed-reactive PCs and
incubating with secondary reagent (anti-dig-Cy5) alone
returned no staining (Additional file 1: Figure S1). For
comparison, the standard method for detecting dsDNA-
specific PCs via enzymatic or immunofluorescence
ELISpot is shown as Fig. 1b. Both methods, histology
and ELISpot analysis gained comparable results
(Fig. 1c) and matched data sets from NZB/W mice
significantly correlated (Fig. 1d). Likewise, numbers of
dsDNA-specific PCs in the bone marrow and the anti-
dsDNA antibody titer in the serum did (Additional file 2:
Figure S2).
Whether the few dsDNA-specific PCs found in non-
autoimmune C57BL/6 and EAMG mice are false positive
signals marking the threshold for sensitivity of the di-
verse analysis methods or are indeed dsDNA-specific
PCs may be disputed. However, as the dsDNA PCs ap-
peared prominently in old (>5 month) mice and
dsDNA-reactive PCs were already described in C57BL/
mice [22], we tend to the latter.
Parallel staining of pathogenic (dsDNA) and protective
(Ova) plasma cells in histology
As nowadays treatments that deplete LLPCs [23–25] do
not discriminate between protective and pathogenic PCs
and erase the pathogenic and protective humoral memory
alike, comparative studies between self and non-self-
reactive PCs and their niches are essential [1, 26, 27]. For
that purpose, we used the well-established vaccination
model with ovalbumin injection, and stained dsDNA- and
Ova-specific PCs in parallel in autoimmune mice. Five
days after secondary Ova immunization, Ova- and
dsDNA-specific PCs could be detected among PCs of un-
known antigen specificity (Fig. 2a and Additional file 3:
Figure S3a) and no false double-positive PCs were found.
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Fig. 1 Analysis of double-stranded deoxyribonucleic acid (dsDNA)-specific plasma cells (PCs) by histology and ELISpot. a Kryosections from bone
marrows and spleens of autoimmune (NZB/W) and non-autoimmune (C57BL/6) mice were stained with anti-immunoglobulin light chain kappa
(IgL) (PCs, green) and fluorochrome-labeled dsDNA (red, - > dsDNA-specific PCs = yellow) and analyzed by confocal laser scanning microscopy.
b For comparison standard enzymatic ELISpot (dsDNA of all isotypes) and immunofluorescence ELISpot (dsDNA red; IgG, IgA and IgM green) are
depicted. For immunofluorescence ELISpot only 5 % of original cell numbers were seeded to enable counting of total PCs in parallel. c Numbers
of dsDNA-specific PCs acquired by histology and ELISpot. With both methods, dsDNA PCs could be identified in autoimmune (NZB/W) but none
to very few in non-autoimmune (C57BL/6) mice. d In probes from the same NZB/W mice, numbers of dsDNA-specific PCs were assessed by
histology and ELISpot. Data in spleen and bone marrow correlated significantly
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Distinction of dsDNA-reactive plasma cells according to
their Ig class (IgG, IgA, IgM)
The Ig class of autoantibodies has impact on the patho-
genesis of the disease [28] and PCs of different Ig class
or antigen specificity respond differently to therapeutic
treatments, which seems rather due to a manipulation of
their specific niches than a direct effect on the PCs [14].
Thus, future investigations of autoreactive PCs discrimi-
nated by their Ig class seem important. We therefore
counterstained dsDNA-reactive PCs with antibodies
against the Ig heavy chain subclasses (IgG, IgM, and
IgA) (Fig. 2b and Additional file 3: Figure S3B). No false
double-positive Ig-class labeling appeared and in accord-
ance with previous reports [21] our preliminary data in-
dicate that the majority of dsDNA PCs were of IgM and
IgG class while Ova PCs resulting from secondary sys-
temic immunization were mainly of IgG class (data not
shown) [29].
Distinction between long-lived and newly generated
short-lived autoreactive plasma cells
Due to the ubiquitous presence of autoantigens self-
reactive PCs are continuously generated. As such, both
long-lived dsDNA-reactive PCs in their survival niches
and newly generated ones still migrating and competing
for a niche are found at all times but varying in propor-
tion. So far, three methods are possible for the investiga-
tion of LLPCs in their niche. First, via the tracking of
antigen-specific PCs a long time after antigen challenge
(>21 days post boost with e.g., Ova, NP, KLH or CGG)
[19, 30], which is not possible for autoantigens; second,
via the distinction of LLPCs and newly formed PCs due
to the incorporation of bromodeoxyuridine (BrdU) or
for histologic analysis more adequate EdU into the DNA
of proliferating cells [31]; and third, via the staining for
cell cycle proteins such as Ki67 [32]. While the latter
two methods allow distinction of LLPCs and SLPCs, only
the ELISpot method enables the identification of dsDNA-
specific PCs. Therefore, several methods are sometimes
used in parallel e.g., dsDNA ELISpot, BrdU+/- FACS and
histology [7, 21] though still lacking the specific analysis
of dsDNA-reactive LLPCs and their environment.
To enable the distinction between dsDNA-specific
SLPCs and LLPCs, we combined EdU incorporation with
staining for antigen specificity (Fig. 2c). While a propor-
tion of dsDNA-specific and other PCs incorporated EdU
Fig. 2 Parallel analysis of pathogenic (double-stranded deoxyribonucleic acid (dsDNA)-specific) and protective (ovalbumin (Ova)-specific) plasma
cells (PCs), discrimination of dsDNA-specific PCs according to their immunoglobulin (Ig) class (IgA, IgG and IgM) and identification of autoreactive
long-lived plasma cells (LLPCs) and short-lived plasma cells (SLPCs). a Kryosections from spleen of autoimmune mice (NZB/W) - 5 days post
secondary Ova immunization - were stained with anti-Ig light chain kappa (IgL) (PCs, green), fluorochrome-labeled dsDNA (red, - > dsDNA-specific
PCs = yellow) and fluorochrome-labeled Ova (blue, Ova-specific PCs = turquoise). PCs were either specific for dsDNA, Ova or an unknown antigen
but no false double-positive dsDNA/Ova PCs occurred. For comparison, a figure of an immunofluorescence ELISpot identifying Ova (green) and
dsDNA (red) antibody-secreting cells is depicted. b Kryosections from spleen of autoimmune (NZB/W) mice were stained with fluorochrome-
labeled dsDNA (white), anti-IgA (red), anti-IgG (green), anti-IgM (blue). dsDNA-specific PCs were either IgM, IgG or IgA positive. The figures below
depict dsDNA PCs of the IgM (left) and IgG (right) class acquired by ELISpot c Autoimmune (BcN/LmoJ) mice were fed EdU for 2 weeks.
Kryosections from spleen were stained with click-it® EdU kit (EdU positive =white), IgL (PCs, green), fluorochrome-labeled dsDNA (red, - > dsDNA-
specific PCs = yellow). dsDNA-specific SLPC incorporated EdU (lower selection, indicated by arrow in magnification, white-colored nucleus) during
proliferation while dsDNA-specific LLPCs did not (upper selection, indicated by arrow in magnification, blank nucleus)
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indicating their recent generation, LLPCs remained EdU
negative. To confirm the cytoplasmatic staining of dsDNA
and the nuclear localization of EdU we added a nucleus
staining with Sytox Green (Additional file 3: Figure S3C).
Conclusions
Despite their role for autoimmunity, the research on
autoreactive (dsDNA-specific) plasma cells and their
survival niches was hampered by the limitations of the
ELISpot technique as the only available method for the
analysis of dsDNA-specific plasma cells.
The microscopic/histologic detection method described
by us identifies dsDNA-specific plasma cells in equivalent
numbers to the ELISpot technique but furthermore allows
parallel analysis of short- and long-lived dsDNA-specific
plasma cells, comparative characterization of the niches
for pathogenic (dsDNA) and protective (Ova) plasma
cells, and moreover a detailed evaluation of therapeutic
treatments regarding changes of particular plasma cell
subsets or niche components.
Therefore, this analysis method can help to reveal and
understand differences between autoimmune and non-
autoimmune humoral memory and may help to identify
specific targets in the niche for pathogenic plasma cells.
Additional files
Additional file 1: Figure S1. Single fluorescence channels of the
dsDNA staining in tissues from autoimmune and non-autoimmune mice.
(JPEG 6667 kb)
Additional file 2: Figure S2. Correlation between dsDNA-specific
plasma cells numbers in spleen and bone marrow with the anti-dsDNA
antibody titer in the serum. (JPEG 1553 kb)
Additional file 3: Figure S3. Single fluorescence channels of the
combined dsDNA stainings (+Ova and + IgG, +IgA, +IgM and + EdU
respectively). (JPEG 5593 kb)
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